Whats new

Whats new.

goetzpartners securities - BMS shows LAG-3 - PD-1 combo boosts PFS in melanoma

May 20th 2021

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

Go back